Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells

Multiprotein complexes of the mitochondrial electron transport chain form associations to generate supercomplexes. The relationship between tumor cell ability to assemble mitochondrial supercomplexes, tumorigenesis and metastasis has not been studied thoroughly. The mitochondrial and metabolic diffe...

Full description

Bibliographic Details
Main Authors: Joaquín Marco-Brualla, Sameer Al-Wasaby, Ruth Soler, Eduardo Romanos, Blanca Conde, Raquel Justo-Méndez, José A. Enríquez, Patricio Fernández-Silva, Luis Martínez-Lostao, Martín Villalba, Raquel Moreno-Loshuertos, Alberto Anel
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/7/1027
_version_ 1797715361825554432
author Joaquín Marco-Brualla
Sameer Al-Wasaby
Ruth Soler
Eduardo Romanos
Blanca Conde
Raquel Justo-Méndez
José A. Enríquez
Patricio Fernández-Silva
Luis Martínez-Lostao
Martín Villalba
Raquel Moreno-Loshuertos
Alberto Anel
author_facet Joaquín Marco-Brualla
Sameer Al-Wasaby
Ruth Soler
Eduardo Romanos
Blanca Conde
Raquel Justo-Méndez
José A. Enríquez
Patricio Fernández-Silva
Luis Martínez-Lostao
Martín Villalba
Raquel Moreno-Loshuertos
Alberto Anel
author_sort Joaquín Marco-Brualla
collection DOAJ
description Multiprotein complexes of the mitochondrial electron transport chain form associations to generate supercomplexes. The relationship between tumor cell ability to assemble mitochondrial supercomplexes, tumorigenesis and metastasis has not been studied thoroughly. The mitochondrial and metabolic differences between L929dt cells, which lost matrix attachment and MHC-I expression, and their parental cell line L929, were analyzed. L929dt cells have lower capacity to generate energy through OXPHOS and lower respiratory capacity than parental L929 cells. Most importantly, L929dt cells show defects in mitochondrial supercomplex assembly, especially in those that contain complex I. These defects correlate with mtDNA mutations in L929dt cells at the <i>ND2</i> subunit of complex I and are accompanied by a glycolytic shift. In addition, L929dt cells show higher in vivo tumorigenic and metastatic potential than the parental cell line. Cybrids with L929dt mitochondria in L929 nuclear background reproduce all L929dt properties, demonstrating that mitochondrial mutations are responsible for the aggressive tumor phenotype. In spite of their higher tumorigenic potential, L929dt or mitochondrial L929dt cybrid cells are sensitive both in vitro and in vivo to the PDK1 inhibitor dichloroacetate, which favors OXPHOS, suggesting benefits for the use of metabolic inhibitors in the treatment of especially aggressive tumors.
first_indexed 2024-03-12T08:05:48Z
format Article
id doaj.art-5714b53b0c31404bb81c071130c3413b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T08:05:48Z
publishDate 2019-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-5714b53b0c31404bb81c071130c3413b2023-09-02T19:31:58ZengMDPI AGCancers2072-66942019-07-01117102710.3390/cancers11071027cancers11071027Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer CellsJoaquín Marco-Brualla0Sameer Al-Wasaby1Ruth Soler2Eduardo Romanos3Blanca Conde4Raquel Justo-Méndez5José A. Enríquez6Patricio Fernández-Silva7Luis Martínez-Lostao8Martín Villalba9Raquel Moreno-Loshuertos10Alberto Anel11Immunity, Cancer &amp; Stem Cells Group, Department Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Campus San Francisco Square, Aragón Health Research Institute (IIS Aragón), University of Zaragoza, E-50009 Zaragoza, SpainImmunity, Cancer &amp; Stem Cells Group, Department Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Campus San Francisco Square, Aragón Health Research Institute (IIS Aragón), University of Zaragoza, E-50009 Zaragoza, SpainImmunity, Cancer &amp; Stem Cells Group, Department Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Campus San Francisco Square, Aragón Health Research Institute (IIS Aragón), University of Zaragoza, E-50009 Zaragoza, SpainAragón Health Research Institute (IIS Aragón), Center for Research in Biomedicine, E-50009 Zaragoza, SpainDepartment of Human Anatomy and Histology, Faculty of Medicine, Campus San Francisco Square, University of Zaragoza, E-50009 Zaragoza, SpainCarlos III National Center for Cardiovascular Research, 28029 Madrid, SpainCarlos III National Center for Cardiovascular Research, 28029 Madrid, SpainGENOXPHOS Group, Department Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Campus San Francisco Square, Biocomputation and Complex Systems Physics Institute (BIFI), University of Zaragoza, E-50009 Zaragoza, SpainImmunology Department, Lozano Blesa Clinical Hospital, E-50009 Zaragoza, SpainThe National Institute of Biomedical Research (INSERM), Centre Hospitalier Universitaire de Montpellier, The University of Montpellier, The Institute for Regenerative Medicine and Biotherapy, 34090 Montpellier, FranceGENOXPHOS Group, Department Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Campus San Francisco Square, Biocomputation and Complex Systems Physics Institute (BIFI), University of Zaragoza, E-50009 Zaragoza, SpainImmunity, Cancer &amp; Stem Cells Group, Department Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Campus San Francisco Square, Aragón Health Research Institute (IIS Aragón), University of Zaragoza, E-50009 Zaragoza, SpainMultiprotein complexes of the mitochondrial electron transport chain form associations to generate supercomplexes. The relationship between tumor cell ability to assemble mitochondrial supercomplexes, tumorigenesis and metastasis has not been studied thoroughly. The mitochondrial and metabolic differences between L929dt cells, which lost matrix attachment and MHC-I expression, and their parental cell line L929, were analyzed. L929dt cells have lower capacity to generate energy through OXPHOS and lower respiratory capacity than parental L929 cells. Most importantly, L929dt cells show defects in mitochondrial supercomplex assembly, especially in those that contain complex I. These defects correlate with mtDNA mutations in L929dt cells at the <i>ND2</i> subunit of complex I and are accompanied by a glycolytic shift. In addition, L929dt cells show higher in vivo tumorigenic and metastatic potential than the parental cell line. Cybrids with L929dt mitochondria in L929 nuclear background reproduce all L929dt properties, demonstrating that mitochondrial mutations are responsible for the aggressive tumor phenotype. In spite of their higher tumorigenic potential, L929dt or mitochondrial L929dt cybrid cells are sensitive both in vitro and in vivo to the PDK1 inhibitor dichloroacetate, which favors OXPHOS, suggesting benefits for the use of metabolic inhibitors in the treatment of especially aggressive tumors.https://www.mdpi.com/2072-6694/11/7/1027mitochondriadichloroacetatecomplex I<i>ND2</i>metastasiscybrids
spellingShingle Joaquín Marco-Brualla
Sameer Al-Wasaby
Ruth Soler
Eduardo Romanos
Blanca Conde
Raquel Justo-Méndez
José A. Enríquez
Patricio Fernández-Silva
Luis Martínez-Lostao
Martín Villalba
Raquel Moreno-Loshuertos
Alberto Anel
Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells
Cancers
mitochondria
dichloroacetate
complex I
<i>ND2</i>
metastasis
cybrids
title Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells
title_full Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells
title_fullStr Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells
title_full_unstemmed Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells
title_short Mutations in the <i>ND2</i> Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells
title_sort mutations in the i nd2 i subunit of mitochondrial complex i are sufficient to confer increased tumorigenic and metastatic potential to cancer cells
topic mitochondria
dichloroacetate
complex I
<i>ND2</i>
metastasis
cybrids
url https://www.mdpi.com/2072-6694/11/7/1027
work_keys_str_mv AT joaquinmarcobrualla mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT sameeralwasaby mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT ruthsoler mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT eduardoromanos mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT blancaconde mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT raqueljustomendez mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT joseaenriquez mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT patriciofernandezsilva mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT luismartinezlostao mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT martinvillalba mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT raquelmorenoloshuertos mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells
AT albertoanel mutationsintheind2isubunitofmitochondrialcomplexiaresufficienttoconferincreasedtumorigenicandmetastaticpotentialtocancercells